Co-Authors
This is a "connection" page, showing publications co-authored by Ralf Bartenschlager and Hans-Georg Kräusslich.
Connection Strength
0.546
-
Prevalence of SARS-CoV-2 Infection in Children and Their Parents in Southwest Germany. JAMA Pediatr. 2021 06 01; 175(6):586-593.
Score: 0.237
-
From Multiplex Serology to Serolomics-A Novel Approach to the Antibody Response against the SARS-CoV-2 Proteome. Viruses. 2021 04 24; 13(5).
Score: 0.059
-
Microscopy-based assay for semi-quantitative detection of SARS-CoV-2 specific antibodies in human sera: A semi-quantitative, high throughput, microscopy-based assay expands existing approaches to measure SARS-CoV-2 specific antibody levels in human sera. Bioessays. 2021 03; 43(3):e2000257.
Score: 0.058
-
A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Oct 06; 21(1):828.
Score: 0.057
-
Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature. 2020 12; 588(7838):498-502.
Score: 0.056
-
Genome packaging of reovirus is mediated by the scaffolding property of the microtubule network. Cell Microbiol. 2017 12; 19(12).
Score: 0.045
-
Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines. Nucleic Acids Res. 2013 Nov; 41(21):e199.
Score: 0.035